American Society of Addiction Medicine
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)(Learn how and when to remove this template message)
The American Society of Addiction Medicine (ASAM) is an addiction medicine professional society representing over 5,000 physicians, clinicians and associated professionals with a focus on addiction and its treatment.
|Motto||Treat Addiction. Save Lives|
|Kelly J. Clark, MD, MBA, DFAPA, DFASAM|
|Penny S. Mills, MBA|
ASAM has its roots in research and clinical traditions that pre-date its founding in the early 1950s, when Ruth Fox, M.D. began regular meetings with other physicians interested in alcoholism and its treatment at the New York Academy of Medicine. In 1954 these physicians established the New York City Medical Society on Alcoholism (later expanded as NYCMSA and Other Drug Dependencies) with Dr. Fox as its first President.
ASAM was admitted to the American Medical Association (AMA) House of Delegates as a voting member in June 1988, and in June 1990 the AMA added addiction medicine (ADM) to its list of designated specialties.
In 1989, to reflect the Society's concern with all drugs of addiction as well as its interest in establishing addiction medicine as part of mainstream medicine, the organization was renamed the American Society of Addiction Medicine (ASAM).
ASAM represents more than 5,000 physicians and associated professionals in the Addiction Medicine Field. Their membership categories include regular members, early career physicians, residents, medical students and associate members. Members have access to textbooks, guidelines, the ASAM criteria, continuing medical education workshops, and live and online courses.
Annual conference and meetingsEdit
Part of ASAM's mission is to educate providers and the public about the practice of Addiction Medicine.
ASAM is critical of the current regulatory state of marijuana, holding that there is no such thing as appropriate medical use of the plant cannabis; in 2010, the society published a white paper calling for federal regulations to oversee research and development of cannabis based medicines and issued recommendations for state medical authorities to "...assure that physicians who choose to discuss the medical use of cannabis and cannabis-based products with patients...[a]dhere to the established professional tenets of prr patient care..."; in 2012 the society stated that there is no "Medical marijuana" because the plant parts in question fails to meet the standard requirements for approved medicines, that Marijuana has many serious, negative health effects.
Journal of Addiction MedicineEdit
Published six times per year, the Journal of Addiction Medicine (JAM) is the official journal of the American Society of Addiction Medicine. The mission of JAM is to promote excellence in the practice of addiction medicine and in clinical research as well as to support addiction medicine as a mainstream medical specialty.
- The ASAM Criteria, (2013) ISBN 978-1-61702-197-8
- The ASAM Essentials of Addiction Medicine, (2015), ISBN 9781451194463
- The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
- The ASAM Handbook of Addiction Medicine, 2015 ( ISBN 9780190214647)
- The ASAM Handbook on Pain and Addiction, 2017 ( ISBN 9780190265366)
- The Principles of Addiction Medicine, sixth edition 2018, ( ISBN 9781496371010)
- The ASAM Weekly (e-Newsletter)
|1954–1961||Ruth Fox, MD|
|1961–1963||Stanley Gitlow, MD|
|1963–1965||Luther A. Cloud, MD|
|1965–1967||Percy E. Ryberg, MD|
|1967–1969||Arnold S. Zentner, MD|
|1969–1971||Ruth Fox, MD|
|1971–1973||Stanley Gitlow, MD|
|1973–1975||Maxwell N. Weisman, MD|
|1975–1977||Charles S. Lieber, MD|
|1977–1979||Joseph J. Zuska, MD|
|1979–1981||Sheila B. Blume, MD|
|1981–1983||LeClair Bissell, MD|
|1983–1985||Irvin L. Blose, MD|
|1985–1987||Max A. Schneider, MD|
|1987–1989||Margaret Bean-Bayog, MD|
|1989–1991||Jasper G. Chen See, MD|
|1991–1993||Anthony B. Radcliffe, MD|
|1993–1995||Anne Geller, MD|
|1995–1997||David E. Smith, MD|
|1997–1999||G. Douglas Talbott, MD|
|1999–2001||Marc Galanter, MD, FASAM|
|2001–2002||Andrea Barthwell, MD, FASAM|
|2002–2005||Lawrence S. Brown, Jr., MD|
|2005–2007||Elizabeth F. Howell, MD|
|2007–2009||Michael M. Miller, MD|
|2009–2011||Louis E. Baxter, Sr., MD, FASAM|
|2011–2013||Donald J. Kurth, MD|
|2013–2015||Stuart Gitlow, MD, MPH, MBA, DFAPA, DFASAM|
|2015–2017||R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM|
|2017-2019||Kelly J. Clark, MD, MBA, DFAPA, DFASAM|
- "American Society of Addiction Medicine Inc." Exempt Organization Select Check. Internal Revenue Service. Accessed on May 22, 2016.
- "Form 990: Return of Organization Exempt from Income Tax". American Society of Addiction Medicine. Guidestar. December 31, 2014.
- "Board of Directors". American Society of Addiction Medicine. Accessed on May 22, 2016.
- "ASAM Staff". American Society of Addiction Medicine. Accessed on May 22, 2016.